On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Elanco Animal Health Incorporated (NYSE:ELAN) . “They are doing everything right. I am so impressed with the way they've turned that company around,” he added.Lending support to his choice, Barclays analyst Glen Santangelo, on Dec. 9, initiated coverage on Elanco Animal Health with an Overweight rating and announced a price target of $30.Rocket Lab Corporation (NASDAQ:RKLB) is a “very good spec, ahead of another big offering in the rocket ...